Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 17 04:00PM ET
79.08
Dollar change
-0.17
Percentage change
-0.21
%
IndexS&P 500 P/E25.08 EPS (ttm)3.15 Insider Own0.07% Shs Outstand1.33B Perf Week-3.95%
Market Cap105.00B Forward P/E14.51 EPS next Y5.45 Insider Trans-3.78% Shs Float1.33B Perf Month-5.47%
Income4.20B PEG7.21 EPS next Q1.45 Inst Own85.26% Short Float0.94% Perf Quarter-8.10%
Sales32.32B P/S3.25 EPS this Y-1.77% Inst Trans1.45% Short Ratio1.94 Perf Half Y10.22%
Book/sh38.95 P/B2.03 EPS next Y4.91% ROA4.54% Short Interest12.43M Perf Year-3.70%
Cash/sh6.27 P/C12.62 EPS next 5Y3.48% ROE8.14% 52W Range68.84 - 92.02 Perf YTD-4.01%
Dividend Est.2.64 (3.34%) P/FCF21.29 EPS past 5Y4.43% ROI5.53% 52W High-14.06% Beta0.80
Dividend TTM2.76 (3.49%) Quick Ratio1.71 Sales past 5Y0.91% Gross Margin60.32% 52W Low14.88% ATR (14)1.44
Dividend Ex-DateMar 21, 2024 Current Ratio2.30 EPS Y/Y TTM3.59% Oper. Margin18.50% RSI (14)30.06 Volatility1.86% 1.56%
Employees95000 Debt/Eq0.49 Sales Y/Y TTM5.03% Profit Margin13.00% Recom2.35 Target Price93.83
Option/ShortYes / Yes LT Debt/Eq0.47 EPS Q/Q8.21% Payout96.47% Rel Volume0.87 Prev Close79.25
Sales Surprise1.71% EPS Surprise3.04% Sales Q/Q4.68% EarningsFeb 20 BMO Avg Volume6.40M Price79.08
SMA20-5.42% SMA50-6.31% SMA200-3.36% Trades Volume5,592,571 Change-0.21%
Date Action Analyst Rating Change Price Target Change
Jul-19-23Initiated Robert W. Baird Neutral $90
Jun-30-23Initiated CL King Buy $106
May-30-23Upgrade Morgan Stanley Equal-Weight → Overweight $104
Apr-24-23Upgrade Wells Fargo Equal Weight → Overweight $77 → $100
Mar-29-23Downgrade UBS Buy → Sell $127 → $79
Jan-09-23Downgrade RBC Capital Mkts Outperform → Sector Perform $102 → $89
Nov-23-22Downgrade Oppenheimer Outperform → Perform $106 → $85
Nov-23-22Downgrade Citigroup Buy → Neutral $108 → $85
Nov-16-22Downgrade Deutsche Bank Buy → Hold $85
Oct-18-22Initiated Barclays Equal Weight $90
Today 07:02AM
Apr-16-24 05:50PM
04:55AM
Apr-15-24 07:35AM
Apr-13-24 12:18PM
09:00AM Loading…
Apr-12-24 09:00AM
08:00AM
Apr-11-24 09:17PM
09:31AM
06:15AM
06:05AM
Apr-10-24 05:50PM
09:27AM
08:45AM
08:30AM
08:33PM Loading…
Apr-09-24 08:33PM
Apr-08-24 10:15AM
08:00AM
01:53AM
Apr-07-24 09:45AM
08:00AM
Apr-04-24 05:50PM
Apr-02-24 10:28AM
Apr-01-24 08:15AM
Mar-31-24 02:17PM
07:45AM
06:20AM
Mar-27-24 04:17PM
09:00AM
08:00AM
04:50AM Loading…
04:50AM
Mar-26-24 10:00AM
08:02AM
05:10AM
01:20AM
Mar-24-24 07:48AM
Mar-23-24 03:46AM
Mar-22-24 01:41AM
Mar-21-24 02:51PM
11:30AM
09:45AM
08:19AM
Mar-20-24 07:34AM
07:02AM
Mar-18-24 03:30AM
Mar-17-24 02:36PM
04:45AM
Mar-15-24 06:00AM
Mar-14-24 09:15AM
08:02AM
Mar-13-24 04:30PM
08:00AM
Mar-12-24 08:03AM
06:00AM
Mar-11-24 09:17AM
Mar-09-24 05:40AM
Mar-08-24 09:15AM
06:52AM
Mar-07-24 04:20PM
Mar-06-24 08:37AM
06:34AM
Mar-05-24 04:30PM
06:37AM
04:44AM
Mar-04-24 03:50PM
Mar-01-24 12:22AM
Feb-29-24 09:00AM
07:12AM
Feb-26-24 08:00AM
07:05AM
Feb-25-24 02:37PM
Feb-23-24 11:24PM
Feb-22-24 09:15AM
01:08AM
Feb-21-24 09:53AM
09:52AM
09:15AM
09:04AM
Feb-20-24 09:22PM
04:02PM
02:19PM
02:06PM
01:55PM
12:50PM
12:30PM
12:27PM
10:45AM
10:01AM
09:59AM
09:30AM
08:59AM
08:31AM
08:08AM
07:55AM
07:30AM
07:12AM
07:05AM
06:56AM
06:54AM
06:52AM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Marinaro MichaelEVP & President, Surgical OUApr 08 '24Sale83.1485471,00227,925Apr 09 04:08 PM
Salmon SeanEVP & President CardiovascularFeb 21 '24Option Exercise69.0730,6952,120,12178,984Feb 23 05:18 PM
Salmon SeanEVP & President CardiovascularFeb 21 '24Sale85.1330,6952,613,05548,289Feb 23 05:18 PM
Wall Brett A.EVP & Pres NeuroscienceDec 19 '23Sale82.174,997410,60328,910Dec 20 11:41 AM
Smith Gregory LEVP Global Ops & Supply ChainAug 23 '23Sale83.8410,000838,40046,723Aug 25 03:21 PM
Wall Brett A.EVP & Pres NeuroscienceAug 14 '23Sale83.381,00083,38033,573Aug 16 05:16 PM
Marinaro MichaelEVP & President, Surgical OUAug 04 '23Sale84.111,352113,71728,930Aug 07 08:47 PM
Wall Brett A.EVP & Pres NeuroscienceJul 14 '23Sale87.972,000175,94023,948Jul 18 04:16 PM
TEN HOEDT ROBEVP and Pres. Global RegionsJul 10 '23Option Exercise55.325,514305,03447,508Jul 12 03:48 PM
TEN HOEDT ROBEVP and Pres. Global RegionsJul 10 '23Sale86.585,514477,42043,802Jul 12 03:48 PM